XML 81 R67.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes - Additional Information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Income Taxes [Line Items]      
Non-current deferred tax assets $ 12.7   $ 13.5
Amount of valuation allowance increased (decreased) 2.2 $ (8.0)  
Net deferred tax liabilities 81.1 69.4  
Excess tax benefits realized 12.7 3.4  
Excess tax benefits attributable to deferred tax asset 54.4 61.1  
Deferred tax liability not recognized, Amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries 0.0    
Cumulative effect $ 0.0    
Income tax returns examination The Company's income tax returns for the following jurisdictions are currently under examination New Jersey State income tax returns for the years ended June 30, 2007 through 2013; New York State income tax return for the years ended June 30, 2014 through 2015; and U.S. income tax return for the year June 30, 2014.    
New Accounting Pronouncement, Early Adoption, Effect      
Income Taxes [Line Items]      
Amount of valuation allowance increased (decreased) $ 3.8    
Sividon Diagnostics GmbH      
Income Taxes [Line Items]      
Net deferred tax liabilities 13.2    
UTAH | Prior to the adoption of Statement 123(R)      
Income Taxes [Line Items]      
Excess tax benefits attributable to deferred tax asset 6.8    
South San Francisco, California      
Income Taxes [Line Items]      
Amount of valuation allowance increased (decreased)   (11.5)  
Foreign net operating losses and state tax research credits      
Income Taxes [Line Items]      
Amount of valuation allowance increased (decreased)   3.5  
Foreign Net Operating Losses      
Income Taxes [Line Items]      
Amount of valuation allowance increased (decreased)   $ (3.5)  
State Research Tax Credit Carryforward      
Income Taxes [Line Items]      
Amount of valuation allowance increased (decreased) $ 1.9